Peak6 Investments LLC Gilead Sciences, Inc. Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

A detailed history of Peak6 Investments LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 100,100 shares of GILD stock, worth $8.85 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

100,100

Previous 371,500 73.06%

Holding current value

$8.85 Million

Previous $25.5 Million 67.08%

% of portfolio

0.02%

Previous 0.07%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $182,483 - $199,093	2,468 Added 244.36%	3,478 $260,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $76,770 - $87,567	1,010 New	1,010 $77,000
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $152,870 - $219,469	2,453 New	2,453 $211,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $6.04 Million - $6.8 Million	-104,630 Reduced 91.39%	9,857 $609,000
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $4.99 Million - $6.25 Million	86,135 Added 303.81%	114,487 $6.81 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $8.12 Million - $9.22 Million	-125,150 Reduced 81.53%	28,352 $2.06 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $5.53 Million - $5.97 Million	81,693 Added 113.76%	153,502 $10.7 Million
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $2.71 Million - $2.96 Million	-42,669 Reduced 37.27%	71,809 $4.94 Million
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $4.62 Million - $5.27 Million	-76,917 Reduced 40.19%	114,478 $7.4 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $5.04 Million - $5.75 Million	-89,019 Reduced 31.75%	191,395 $11.2 Million
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $12.6 Million - $15.8 Million	202,705 Added 260.85%	280,414 $17.7 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $9.15 Million - $10.6 Million	-126,504 Reduced 61.95%	77,709 $5.98 Million
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $759,701 - $973,068	-12,130 Reduced 5.61%	204,213 $15.3 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $8.8 Million - $9.67 Million	142,740 Added 193.93%	216,343 $14.1 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $1.59 Million - $1.76 Million	-25,481 Reduced 25.72%	73,603 $4.67 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $4.62 Million - $5.18 Million	-74,647 Reduced 42.97%	99,084 $6.69 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $7.93 Million - $8.88 Million	-126,753 Reduced 42.18%	173,731 $11.3 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $6.5 Million - $8.48 Million	107,286 Added 55.53%	300,484 $18.8 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $13.8 Million - $15.2 Million	193,198 New	193,198 $14.9 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account

Peak6 Investments LLC Gilead Sciences, Inc. Transaction History